Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Total Body Irradiation Creates a Proinflammatory Milieu That Is Required for Minor, but Not Major, Mismatch Graft-Versus-Host-Disease.

Sam C Nalle, Peter A Savage, PhD, Jerrold R Turner, MD, PhD

Blood (2010) 116 (21): 3736.

https://doi.org/10.1182/blood.V116.21.3736.3736

Published: 2010

Journal Articles

TP53 Deletion in CLL: The Significance of Borderline Level Deletion

Sheila J.M. O’Connor, PhD, Kathryn R Turner, MSc, Bradley Dickinson, MSc, Sharon L Barrans, PhD, Roger G Owen, Andrew Jack, PhD, MB, Peter Hillmen, MBChB, PhD

Blood (2008) 112 (11): 4178.

https://doi.org/10.1182/blood.V112.11.4178.4178

Published: 2008

Journal Articles

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

C. Shustik, R. Turner, P. Desjardins, L. Fernandez, S. Rubin, L. Larratt, A. Duncan, D. Rizi, A. Sadura, L. Shepherd, D. Li, L. Rassenti, T. Kipps

Blood (2005) 106 (11): 2977.

https://doi.org/10.1182/blood.V106.11.2977.2977

Published: 2005

Journal Articles

Upregulation of MT1-MMP Expression by Hyaluronic Acid Enhances Homing-Related Responses of Hematopoietic CD34 + Cells to an SDF-1 Gradient.

Neeta Shirvaikar, MSc, Jencet Montano, BSc, Andrew R. Turner, MD, Mariusz Z. Ratajczak, MD, PhD, Anna Janowska-Wieczorek, MD, PhD

Blood (2004) 104 (11): 2889.

https://doi.org/10.1182/blood.V104.11.2889.2889

Published: 2004

Journal Articles

High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.

Rena Buckstein, M. Crump, Y. Shaked, D. Spaner, E. Piliotis, K. Imrie, R. Nayar, C. Foden, R. Turner, D. Taylor, S. Man, S. Baruchel, D. Stempak, I. Quirt, J. Sturgeon, F. Bertolini, R.S. Kerbel

Blood (2004) 104 (11): 4622.

https://doi.org/10.1182/blood.V104.11.4622.4622

Published: 2004

NARROW

Total Body Irradiation Creates a Proinflammatory Milieu That Is Required for Minor, but Not Major, Mismatch Graft-Versus-Host-Disease.

TP53 Deletion in CLL: The Significance of Borderline Level Deletion

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

Upregulation of MT1-MMP Expression by Hyaluronic Acid Enhances Homing-Related Responses of Hematopoietic CD34 + Cells to an SDF-1 Gradient.

High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.

Email alerts

ASH Publications

American Society of Hematology

Total Body Irradiation Creates a Proinflammatory Milieu That Is Required for Minor, but Not Major, Mismatch Graft-Versus-Host-Disease.

TP53 Deletion in CLL: The Significance of Borderline Level Deletion

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

Upregulation of MT1-MMP Expression by Hyaluronic Acid Enhances Homing-Related Responses of Hematopoietic CD34 + Cells to an SDF-1 Gradient.

High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only